Tag: life sciences
-
Enrollment Completed in Aging Frailty Stem Cell Trial
A company developing stem cell treatments to counter frailty in older people finished enlisting participants in a clinical trial testing its therapies.
-
Engineered Bacteria Deliver Cancer Immunotherapy
13 Feb. 2020. A biomedical engineering team designed probiotic bacteria, which in lab mice are shown to deliver and enhance cancer immunotherapy drugs. Researchers at Columbia University in New York describe their engineered bacteria and findings in yesterday’s issue of the journal Science Translational Medicine (paid subscription required). Treatments that invoke the immune system to…
-
Synthetic Cell Matrix Devised for Cancer Drug Testing
A bioengineering lab is creating synthetic cell scaffolds that simulate tumor cells and tissue, offering a more reliable way of testing new cancer drugs.
-
Janssen, BARDA Partner on Coronavirus Vaccine
An industry-government collaboration aims to advance and produce vaccines against the 2019 novel coronavirus outbreak in China and elsewhere.
-
Nasal Spray Reduces Migraine-Related Stress, Peptides
A hormone resembling insulin given as a nasal spray is shown in lab rats to reduce stress on nerve cells and peptides associated with migraine pain.
-
A.I. Heart Ultrasound Software Cleared by FDA
Software guided by algorithms that capture top-quality ultrasound images of the heart is now authorized by the Food and Drug Administration.
-
Incubator Seeks Heart, Lung, Blood Device Entrepreneurs
A business incubator in Massachusetts is seeking entrepreneurs and their companies developing medical devices for heart, lung, blood, and sleep disorders.
-
Smartphone Saliva Test Detects Infectious Diseases
A university engineering lab designed a simple, inexpensive point-of-care device, powered by a smartphone, to detect infectious and other diseases.
-
Gene Therapy Licensed for Multiple Aging Diseases
A university spin-off company developing treatments to extend the lifetimes of dogs is gaining a gene therapy for preventing multiple age-related diseases.
-
Blood Cancers Respond to Cord Blood Cells
A small-scale clinical trial shows most patients with two blood-related cancers safely respond to immune system cells derived from umbilical cord blood.